Search Results 191-200 of 18957 for Neutrophil

  1. AZD5305 Vs Placebo In Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - Mayo Clinic

    Absolute neutrophil count ≥ 1.5 × 10^9 /L with no growth factor support in the 28 days prior to randomisation;. Platelet count ≥ 100 × 10^9 /L;. Serum ...

  2. A Trial of the Effectiveness, Safety, and Tolerability of a Single Oral Administration of CP101 for the Prevention of Recurrent Clostridioides difficile Infection (PRISM4) - Mayo Clinic

    ... neutrophil count of < 1 × 10^9 neutrophils/L, or laboratory evidence of acute kidney injury at Investigators discretion, at Screening. Screening ...

  3. Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer - Mayo Clinic

    - Absolute neutrophil count >= 1,500/mcL - Platelets >= 100,000/mcL - Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) - Aspartate ...

  4. A Study to Evaluate the Safety and Effectiveness of TT-00420 in Adults with Advanced Cholangiocarcinoma - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1.5 x 10^9 /L;; Hemoglobin (Hgb) ≥ 8 g/dl;; Platelets (plt) ≥ 75 x 10^9 /L;; AST/SGOT and ALT/SGPT ≤ 2.5 x Upper Limit of ...

  5. Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405) - Mayo Clinic

    - Absolute Neutrophil Count (ANC) ≥ 1000/mm³ - Hemoglobin ≥ 8 g/dL - Platelets ?75,000/mm³ - Creatinine clearance ≥ 40 mL/min, calculated with the use of ...

  6. Daratumumab in Cardiac HLA Desensitization Prior to Transplantation - Mayo Clinic

    The objectives of this study is to evaluate the efficacy of Daratumumab as an HLA desensitization strategy prior to cardiac transplantation in highly-sensitized ...

  7. Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer - Mayo Clinic

    absolute neutrophil count (ANC) must be greater than or equal to 1200/mm^3;; platelet count must be greater than or equal to 100,000/mm^3; and; hemoglobin ...

  8. Safety and Tolerability of TAR-200 in Subjects With Muscle-Invasive Bladder Cancer Who Are Unfit for Radical Cystectomy - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1,500/mm^3;; Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 2x the upper limit of normal (ULN);; Alanine ...

  9. Androgen-Deprivation Therapy And Radiation Therapy In Treating Patients With Prostate Cancer - Mayo Clinic

    ... neutrophil count (ANC) ≥ 1,500/mm³ - Platelet count ≥ 100,000/mm³ - Hemoglobin (Hgb) ≥ 8.0 g/dL (transfusion or other intervention to achieve Hgb ≥ 8.0 ...

  10. Veliparib with or without Carboplatin in Treating Patients with Stage III or Stage IV Breast Cancer - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1,500/mcL; Platelet count ≥ 100,000/mcL; Total bilirubin ≤ 1.5 times institutional upper limit of normal; Aspartate ...